Abstract
Sexuality, with its fundamental connection to reproduction, has been the subject of sustained and inordinate interest among all cultures since prehistoric ages. Sexual dysfunctions have been experienced as devastating problems to mankind since the beginning of recorded time, evidenced by Stone Age wall paintings and biblical references. The material contained in this volume’s previous pages support sexual medicine as a postmodern, twenty-first-century solution to that prebiblical problem.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
While some referrals for ED were lost to mental health professionals, contrary to media hype, the introduction of sildenafil expanded opportunities for sex therapists. Sex therapy was reinvigorated with a new treatment tool, which expanded the number and range of individuals who could be restored to sexual health.
- 2.
2On August 18, 2015 the U.S. Food and Drug Administration approved Addyi (flibanserin) to treat acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women, but with risk evaluation and mitigation strategies (REMS) required. “Today’s approval provides women distressed by their low sexual desire with an approved treatment option,” said Dr. Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research (CDER) adding, “Because of a potentially serious interaction with alcohol, treatment with Addyi will only be available through certified health care professionals and certified pharmacies.”
- 3.
Sex therapists have expanded their impact through public and colleague education. In terms of public education, media exposure broadened the scope, range, and size of the general audience who heard a sex therapy message integrated into open discussion. There was unprecedented opportunity with colleague education to reach non-sex therapy professionals with a psychological message. Primary care physicians and urologists learned that incorporating sex therapy techniques improved the effectiveness of sildenafil. Furthermore, sex therapists discovered that integrating adjunctive use of sildenafil with sex therapy accelerated the therapy process and improved outcome.
- 4.
The STP model is a registered trademark of the MAP Education and Research Fund, a 501(c)(3) public charity. STP illustrations are available free from mapedfund.org.
References
Perelman MA. The history of sexual medicine. In: Diamond L, Tolman D, editors. APA handbook of sexuality and psychology. Washington, DC: American Psychological Association; 2014.
Perelman MA. The impact of the new sexual pharmaceuticals on sex therapy. Curr Psychiatry Rep. 2001;3(3):195–201.
Masters W, Johnson V. Human sexual inadequacy. New York, NY: Little Brown; 1970.
Kaschak E, Tiefer L. A new view of women’s sexual problems. New York, NY: Haworth Press; 2001.
Moser C. Sexual medicine, sex therapy, and sexual health care. In: Kleinplatz PJ, editor. New directions in sex therapy: innovations and alternatives. New York, NY: Routledge; 2012.
Perelman MA. Rehabilitative sex therapy for organic impotence. In: Segraves T, Haeberle E, editors. Emerging dimensions of sexology. New York: Praeger; 1984. p. 181–8.
Zarembo A. Clinic settles lawsuits but still faces scrutiny over erectile dysfunction injections. Los Angeles Times. 2 April 2011.
Kleinplatz PJ. New directions in sex therapy: innovations and alternatives. New York, NY: Routledge; 2012.
Tiefer L. Three crises facing sexology. Arch Sex Behav. 1994;23(4):361–74.
McCarthy BW, Fucito LM. Integrating medication, realistic expectations, and therapeutic interventions in the treatment of male sexual dysfunction. J Sex Marital Ther. 2005;31(4):319–28.
Althof S. Therapeutic weaving: the integration of treatment techniques. In: Levine S, editor. Handbook of clinical sexuality for mental health professionals. New York: Brunner-Routledge; 2003. p. 359–76.
Perelman MA. Sex coaching for physicians: combination treatment for patient and partner. Int J Impot Res. 2003;15 Suppl 5:S67–74.
Perelman MA. The impact of relationship variables on the etiology, diagnosis and treatment of erectile dysfunction. Adv Primary Care Med Clin Update. 2007;3:3–6.
Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA. 1999;281(6):537–44.
Martin B, Richards E. Scientific knowledge, controversy, and public decision making. In: Jasanoff S, Markle GE, Petersen JC, Pinch TJ, editors. Handbook of science and technology studies. Thousand Oaks, CA: SAGE; 1995.
Huynh HK, Beers C, Willemsen A, Lont E, Laan E, Dierckx R, et al. High-intensity erotic visual stimuli de-activate the primary visual cortex in women. J Sex Med. 2012;9(6):1579–87.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this chapter
Cite this chapter
Perelman, M.A. (2016). Epilogue: Cautiously Optimistic for the Future of a Transdisciplinary Sexual Medicine. In: Lipshultz, L., Pastuszak, A., Goldstein, A., Giraldi, A., Perelman, M. (eds) Management of Sexual Dysfunction in Men and Women. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-3100-2_35
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3100-2_35
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-3099-9
Online ISBN: 978-1-4939-3100-2
eBook Packages: MedicineMedicine (R0)